MedTrace Logo

Paclitaxel Releasing Balloon in Patients Presenting With In-Stent Restenosis

NCT00961181 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2013-05-06

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to evaluate the safety and efficacy of the paclitaxel releasing balloon in patients with in-stent restenosis in a coronary artery.

Conditions

  • In-stent Coronary Artery Restenosis

Interventions

DEVICE

Paclitaxel Releasing Balloon

Percutaneous coronary intervention with paclitaxel releasing balloon

Sponsors & Collaborators

  • Biotronik AG

    lead INDUSTRY

Principal Investigators

  • Christoph Hehrlein, MD · University Medical Center, Freiburg i.Br., Germany

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-12-31
Completion
2011-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00961181 on ClinicalTrials.gov